Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

Phase 2

Completed

Conditions: Diabetic Macular Edema

Interventions: Drug: ranibizumab

First Posted Date: 2010-03-01

Last Posted Date: 2017-04-28

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 152

Registration Number: NCT01077401

Locations: 🇺🇸
Retina Group of Florida, Fort Lauderdale, Florida, United States
🇺🇸
Texas Retina Associates, Arlington, Texas, United States
🇺🇸
University of Kansas, Prairie Village, Kansas, United States

and more 10 locations

Left Ventricular Structural Predictors of Sudden Cardiac Death

Recruiting

Conditions: Nonischemic Cardiomyopathy
Ischemic Cardiomyopathy

First Posted Date: 2010-02-26

Last Posted Date: 2025-01-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 400

Registration Number: NCT01076660

Locations: 🇺🇸
Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
🇺🇸
Christiana Care Health Services, Newark, Delaware, United States

Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study

Not Applicable

Completed

Conditions: Coronary Heart Disease

Interventions: Device: Intermittent pneumatic compression of the lower extremities

First Posted Date: 2010-02-08

Last Posted Date: 2017-08-17

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 10

Registration Number: NCT01064323

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Sleep Apnea Treatment With Expiratory Resistance(Provent™)

Phase 1

Completed

Conditions: Sleep Apnea, Obstructive

Interventions: Device: Treatment sleep study (Provent™ device used)
Other: Baseline sleep study (No device)
Other: Physiology sleep study (Provent™ on/off)

First Posted Date: 2010-02-03

Last Posted Date: 2013-07-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 12

Registration Number: NCT01061476

Locations: 🇺🇸
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States

Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance

Not Applicable

Completed

Conditions: Neurobehavioral Manifestations
Sleep Deprivation
Dyssomnias

Interventions: Behavioral: Sleep promoting interventions

First Posted Date: 2010-02-03

Last Posted Date: 2011-06-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 88

Registration Number: NCT01061242

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus (HIV)

Interventions: Biological: Radiolabeled autologous seminal fluid
Biological: Radiolabeled Normosol-R

First Posted Date: 2010-01-21

Last Posted Date: 2017-05-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 11

Registration Number: NCT01053741

Locations: 🇺🇸
Johns Hopkins University Drug Development Unit, Baltimore, Maryland, United States

Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment

Phase 1

Completed

Conditions: Hepatitis C
HIV

Interventions: Drug: Ribavirin plus Abacavir (ABC)
Drug: Ribavirin

First Posted Date: 2010-01-20

Last Posted Date: 2017-05-01

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 26

Registration Number: NCT01052701

Locations: 🇺🇸
Johns Hopkins Drug Development Unit, Baltimore, Maryland, United States

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

Phase 2

Completed

Conditions: Mild Cognitive Impairment (MCI)

Interventions: Drug: Levetiracetam 62.5mg
Drug: Levetiracetam 125mg
Drug: Levetiracetam 250mg
Drug: Placebo

First Posted Date: 2010-01-08

Last Posted Date: 2017-08-21

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 96

Registration Number: NCT01044758

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

Phase 4

Completed

Conditions: Pulmonary Arterial Hypertension
Pulmonary Hypertension
Systemic Sclerosis
Scleroderma Spectrum of Diseases
Connective Tissue Disease

Interventions: Drug: tadalafil and ambrisentan upfront combination therapy

First Posted Date: 2010-01-05

Last Posted Date: 2017-09-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 25

Registration Number: NCT01042158

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Contingency Management in the Delivery of HAART to Drug Users in Chennai, India

Phase 2

Completed

Conditions: HIV
Substance Abuse, Intravenous

Interventions: Behavioral: Contingency
Other: Prize bowl drawings

First Posted Date: 2009-12-15

Last Posted Date: 2016-11-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 120

Registration Number: NCT01031745

Locations: 🇮🇳
YR Gaitonde Centre for Substance Abuse-Related Research (YRGCSAR), Chennai, Tamil Nadu, India

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy